About Long Bridge Medical
Long Bridge Medical is a private company based in South San Francisco, California. It has reported $7,154,955 raised in three offerings on Form D since November 2023. Its chief executive is Ayman Naseri.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 17, 2025 | Aug 13, 2026 | $2,540,000of $5.0M target | 29 | $87,586 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 15, 2024 | Mar 12, 2025 | $999,992of $999K target | 15 | $66,666 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 20, 2023 | Nov 3, 2023 | $3,614,963of $4.9M target | 33 | $109K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $7,154,955 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Long Bridge Medical's Form D filed Aug 13, 2026.
EM
Eugene de Juan Jr., MD
Director
MC
Matthew Clarke
Executive officer
AN
Ayman Naseri
CEO and director
DC
David Chang
Director